CVR number 28693826
Industry 75.0000 Veterinary activities

Farum Dyreklinik ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  15.5% 5.7% 6.5% 4.0% 6.1%  
Credit score (0-100)  13 40 35 49 37  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Gross profit  348 268 -51.5 -24.5 5,409  
EBITDA  -72.7 -42.7 -52.2 -59.3 368  
EBIT  -72.7 -42.7 -52.2 -59.3 9.7  
Pre-tax profit (PTP)  -72.9 -115.6 -126.6 -184.6 -360.5  
Net earnings  -72.9 -115.6 423.4 -184.6 -580.5  
Pre-tax profit without non-rec. items  -72.9 -116 -127 -185 -360  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Tangible assets total  0.0 11.4 0.0 0.0 703  
Shareholders equity total  173 57.0 480 296 -285  
Interest-bearing liabilities  0.0 1,144 1,944 2,510 3,083  
Balance sheet total (assets)  197 1,301 2,451 2,826 4,175  
Net Debt  -9.6 963 1,924 2,510 2,632  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  348 268 -51.5 -24.5 5,409  
Gross profit growth  -5.6% -23.0% 0.0% 52.4% 0.0%  
Employees  1 0 0 0 10  
Employee growth %  0.0% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  197 1,301 2,451 2,826 4,175  
Balance sheet change%  -35.5% 560.9% 88.3% 15.3% 47.7%  
Added value  -72.7 -42.7 -52.2 -59.3 368.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 11 -11 0 2,275  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 1.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -20.9% -15.9% 101.4% 242.2% 0.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -28.9% -14.8% -4.0% -3.9% -4.6%  
ROI %  -34.8% -16.2% -4.2% -3.9% -5.6%  
ROE %  -34.9% -100.7% 157.6% -47.6% -26.0%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  87.6% 4.4% 19.6% 10.5% -6.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  13.2% -2,254.1% -3,687.3% -4,233.3% 714.5%  
Gearing %  0.0% 2,007.3% 404.7% 848.6% -1,082.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.8% 3.3% 3.7% 7.0%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  8.1 0.2 0.8 0.4 0.3  
Current Ratio  8.1 0.2 0.8 0.4 0.3  
Cash and cash equivalent  9.6 180.3 19.8 0.0 450.9  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  172.6 -985.6 -387.2 -1,478.6 -3,119.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  -73 0 0 0 37  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -73 0 0 0 37  
EBIT / employee  -73 0 0 0 1  
Net earnings / employee  -73 0 0 0 -58